RCM
EIDX

Riverhead Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Riverhead Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,030
Closed -$40K – 1585
2018
Q3 		$40K Buy
4,030
+2,535
+170% +$25.2K ﹤0.01% 1508
2018
Q2 		$30K Buy
+1,495
New +$30K ﹤0.01% 1501